Case Report
BibTex RIS Cite

Year 2019, , 150 - 159, 30.08.2019

Tugce Uzar Gozde Duyu Ahmet Dirican Selda Gunaydin Nazli Topbasi Hulya Bayiz Şevket Özkaya

https://doi.org/10.17546/msd.564613

Abstract

References

  • 1. Aouadi S, Melki B, Braham E, et al. Eosinophilic lung disease. Eur Respir J 2016; 48.
  • 2. Jeong YJ, Kim K, Seo IJ, et al. Eosinophilic Lung Diseases: A Clinical, Radiologic, and Pathologic Overview. RadioGraphics 2007; 27:617– 639.
  • 3. Bernheim A, McLoud T. A Review of Clnical and Imaging Findings in Eosinophilic Lung Diseases. Am J of Roentgen. 2017;208: 1002-1010.
  • 4. Marchand E, Etienne-Mastroianni B, Chanez P, et al. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J 2003; 22:8.
  • 5. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423–1438.
  • 6. Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000;216:773–780.
  • 7. Campos LE, Pereira LF. Pulmonary eosinophilia. J Bras Pneumol 35: 561-573, 2009.
  • 8. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 27(2): 192-197, 2006.
  • 9. Rizos E, Tsigkaropoulou E, Lambrou P. Risperidone-induced Acute Eosinophilic Pneumonia. In Vivo 2013;27 (5): 651-653.
  • 10. Mann B. Eosinophilic lung disease. Clinical medicine. Circulatory, respiratory and pulmonary medicine. 2008 Jan;2:CCRPM-S575.

Evaluation and treatment of the eosinophilic lung diseases in 7 patients

Year 2019, , 150 - 159, 30.08.2019

Tugce Uzar Gozde Duyu Ahmet Dirican Selda Gunaydin Nazli Topbasi Hulya Bayiz Şevket Özkaya

https://doi.org/10.17546/msd.564613

Abstract





Objective:
Eosinophilic lung diseases (ELD) are a rare group of heterogeneous
diseases characterized by the increase of the eosinophilic ratio in the airways
and lung parenchyma. We aimed to present and discuss the clinical, radiologic
and pathologic features of six patients with eosinophilic lung diseases.


Conclusion:
Peripheral eosinophilia with pulmonary infiltrates is diagnostic
clues of eosinophilic lung diseases. Systemic corticosteroids are provided
rapid control not only in symptoms but also radiological and clinical
improvement of ELD.

Keywords

eosinophilic lung diseases acute eosinophilic pneumonia chronic eosinophilic pneumonia Case

References

  • 1. Aouadi S, Melki B, Braham E, et al. Eosinophilic lung disease. Eur Respir J 2016; 48.
  • 2. Jeong YJ, Kim K, Seo IJ, et al. Eosinophilic Lung Diseases: A Clinical, Radiologic, and Pathologic Overview. RadioGraphics 2007; 27:617– 639.
  • 3. Bernheim A, McLoud T. A Review of Clnical and Imaging Findings in Eosinophilic Lung Diseases. Am J of Roentgen. 2017;208: 1002-1010.
  • 4. Marchand E, Etienne-Mastroianni B, Chanez P, et al. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J 2003; 22:8.
  • 5. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423–1438.
  • 6. Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000;216:773–780.
  • 7. Campos LE, Pereira LF. Pulmonary eosinophilia. J Bras Pneumol 35: 561-573, 2009.
  • 8. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 27(2): 192-197, 2006.
  • 9. Rizos E, Tsigkaropoulou E, Lambrou P. Risperidone-induced Acute Eosinophilic Pneumonia. In Vivo 2013;27 (5): 651-653.
  • 10. Mann B. Eosinophilic lung disease. Clinical medicine. Circulatory, respiratory and pulmonary medicine. 2008 Jan;2:CCRPM-S575.
There are 10 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Case Reports
Authors

Tugce Uzar This is me

Gozde Duyu This is me

Ahmet Dirican This is me

Selda Gunaydin This is me

Nazli Topbasi This is me

Hulya Bayiz This is me

Şevket Özkaya

Publication Date August 30, 2019
Published in Issue Year 2019

Cite

APA Uzar, T., Duyu, G., Dirican, A., Gunaydin, S., et al. (2019). Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Medical Science and Discovery, 6(8), 150-159. https://doi.org/10.17546/msd.564613
AMA Uzar T, Duyu G, Dirican A, Gunaydin S, Topbasi N, Bayiz H, Özkaya Ş. Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Med Sci Discov. August 2019;6(8):150-159. doi:10.17546/msd.564613
Chicago Uzar, Tugce, Gozde Duyu, Ahmet Dirican, Selda Gunaydin, Nazli Topbasi, Hulya Bayiz, and Şevket Özkaya. “Evaluation and Treatment of the Eosinophilic Lung Diseases in 7 Patients”. Medical Science and Discovery 6, no. 8 (August 2019): 150-59. https://doi.org/10.17546/msd.564613.
EndNote Uzar T, Duyu G, Dirican A, Gunaydin S, Topbasi N, Bayiz H, Özkaya Ş (August 1, 2019) Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Medical Science and Discovery 6 8 150–159.
IEEE T. Uzar, G. Duyu, A. Dirican, S. Gunaydin, N. Topbasi, H. Bayiz, and Ş. Özkaya, “Evaluation and treatment of the eosinophilic lung diseases in 7 patients”, Med Sci Discov, vol. 6, no. 8, pp. 150–159, 2019, doi: 10.17546/msd.564613.
ISNAD Uzar, Tugce et al. “Evaluation and Treatment of the Eosinophilic Lung Diseases in 7 Patients”. Medical Science and Discovery 6/8 (August 2019), 150-159. https://doi.org/10.17546/msd.564613.
JAMA Uzar T, Duyu G, Dirican A, Gunaydin S, Topbasi N, Bayiz H, Özkaya Ş. Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Med Sci Discov. 2019;6:150–159.
MLA Uzar, Tugce et al. “Evaluation and Treatment of the Eosinophilic Lung Diseases in 7 Patients”. Medical Science and Discovery, vol. 6, no. 8, 2019, pp. 150-9, doi:10.17546/msd.564613.
Vancouver Uzar T, Duyu G, Dirican A, Gunaydin S, Topbasi N, Bayiz H, Özkaya Ş. Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Med Sci Discov. 2019;6(8):150-9.